ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,627Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 670

$793K Total Retail Price of All Prescriptions

Rank: 69 out of 670

535 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 504 312 S3 1 1
LEVOTHYROXINE SODIUM 475 353 2 2
LISINOPRIL 430 351 3 3
SIMVASTATIN 401 367 4 4
OMEPRAZOLE 308 274 5 5
CITALOPRAM HBR 244 184 6 20
GABAPENTIN 237 178 7 11
METOPROLOL SUCCINATE 225 201 8 12
CRESTOR 221 182 9 18
NEXIUM 179 130 10 14
FUROSEMIDE 169 146 11 6
WARFARIN SODIUM 160 159 12 13
METFORMIN HCL 152 124 13 8
METOPROLOL TARTRATE 151 134 14 9
ATENOLOL 137 118 15 17
AMLODIPINE BESYLATE 136 129 16 7
HYDROCHLOROTHIAZIDE 133 108 17 10
DIOVAN 131 109 18 48
PANTOPRAZOLE SODIUM 130 116 19 41
ZETIA 117 106 20 66
MELOXICAM 116 83 21 33
LOSARTAN POTASSIUM 104 99 22 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 80 22 27
PRADAXA 98 76 24 187
ATORVASTATIN CALCIUM 98 69 24 15
SPIRONOLACTONE 98 82 24 82
ZOLPIDEM TARTRATE 94 74 27 23
KLOR-CON M20 89 86 28 57
LOVAZA 89 72 28 108
FLUTICASONE PROPIONATE 89 67 28 37
PRAVASTATIN SODIUM 86 82 31 19
TORSEMIDE 83 77 32 100
CARVEDILOL 81 64 33 29
ALLOPURINOL 78 64 34 38
TRAMADOL HCL 74 61 35 21
DIGOXIN 74 69 35 46
CYMBALTA 72 47 37 36
MIRTAZAPINE 71 69 38 59
DONEPEZIL HCL 71 71 38 31
CEPHALEXIN 70 58 40 102
PROAIR HFA 68 45 41 28
CLOPIDOGREL 64 38 42 24
FENOFIBRATE 60 21 43 64
RANITIDINE HCL 60 53 43 25
METHYLPREDNISOLONE 59 45 45 120
ESCITALOPRAM OXALATE 58 50 46 78
GLIMEPIRIDE 58 46 46 32
ROPINIROLE HCL 57 24 48 75
NAMENDA 54 54 49 54
LOVASTATIN 54 38 49 44
SERTRALINE HCL 54 47 49 22
DIOVAN HCT 51 51 52 126
VENLAFAXINE HCL ER 50 44 53 97
LANTUS 50 39 53 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.